Updated Story Senate Finance Committee Chair Ron Wyden (D-OR) says he will work on bipartisan legislation to address the issue of three wholesalers controlling 90% of the pharmaceutical market, saying highly consolidated middlemen like wholesalers and group purchasing organizations (GPOs) are contributing to the drug shortage crisis -- a concern that aligns with that of the generic drug lobby Association for Accessible Medicine (AAM). Industry experts testifying at a Finance Committee hearing Tuesday (Dec. 5) pushed the...